X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-02-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $19.59 | -3,126 | 64,689 | -5% | -$61,238 | ||||||
2023-01-25 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $21.07 | -8,336 | 67,815 | -11% | -$175,640 | ||||||
2023-01-17 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.00 | -3,126 | 76,151 | -4% | -$56,268 | ||||||
2023-01-03 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.35 | -3,126 | 79,277 | -4% | -$57,362 | ||||||
2022-12-15 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $16.00 | -3,126 | 82,403 | -4% | -$50,016 | ||||||
2022-12-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $17.84 | -3,126 | 84,968 | -4% | -$55,768 | ||||||
2022-11-15 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.72 | -3,126 | 88,094 | -3% | -$58,519 | ||||||
2022-11-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.52 | -3,126 | 91,220 | -3% | -$57,894 | ||||||
2022-10-17 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $17.73 | -3,126 | 94,346 | -3% | -$55,424 | ||||||
2022-10-03 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $19.64 | -3,126 | 97,472 | -3% | -$61,395 | ||||||
2022-09-15 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $21.01 | -4,168 | 100,598 | -4% | -$87,570 | ||||||
2022-09-07 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $21.00 | -1,042 | 104,766 | -1% | -$21,884 | ||||||
2022-09-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.59 | -3,126 | 105,808 | -3% | -$58,112 | ||||||
2022-07-26 | CRNX | Knight Jeff E. | COO | S - Sale | $20.70 | -1,152 | 4,950 | -19% | -$23,847 | ||||||
| D | 2022-07-13 | CRNX | Fust Matthew K | Dir | S - Sale+OE | $20.96 | -5,700 | 12,536 | -31% | -$119,455 | |||||
2022-05-02 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $20.10 | -3,247 | 107,598 | -3% | -$65,252 | ||||||
2022-04-18 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $25.81 | -5,664 | 110,845 | -5% | -$146,188 | ||||||
2022-04-18 | CRNX | Perceptive Advisors LLC | 10% | P - Purchase | $22.22 | +157,515 | 5,321,032 | +3% | +$3,499,983 | ||||||
2022-04-13 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale | $26.83 | -138,643 | 1,059,205 | -12% | -$3,719,625 | ||||||
2022-04-05 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale | $25.34 | -21,357 | 1,197,848 | -2% | -$541,225 | ||||||
2022-04-04 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $23.97 | -9,000 | 116,509 | -7% | -$215,762 | ||||||
| M | 2022-03-31 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $21.43 | -8,328 | 125,509 | -6% | -$178,475 | |||||
2022-03-15 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.94 | -3,123 | 133,837 | -2% | -$59,150 | ||||||
| D | 2022-03-01 | CRNX | Madan Ajay | Chief Development Officer | S - Sale+OE | $19.88 | -9,000 | 176,995 | -5% | -$178,920 | |||||
| D | 2022-03-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale+OE | $19.73 | -3,123 | 136,960 | -2% | -$61,617 | |||||
2022-02-15 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.64 | -3,123 | 123,583 | -2% | -$58,213 | ||||||
2022-02-07 | CRNX | Madan Ajay | Chief Development Officer | S - Sale | $17.83 | -13,411 | 172,045 | -7% | -$239,085 | ||||||
2022-02-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.79 | -3,123 | 126,706 | -2% | -$58,681 | ||||||
| D | 2022-01-19 | CRNX | Krasner Alan Seth | Chief Medical Officer | S - Sale+OE | $21.21 | -6,700 | 8,311 | -45% | -$142,080 | |||||
2022-01-18 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $23.29 | -4,168 | 128,875 | -3% | -$97,073 | ||||||
2022-01-03 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $28.02 | -7,168 | 133,043 | -5% | -$200,847 | ||||||
2021-12-28 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $27.95 | -3,000 | 140,211 | -2% | -$83,852 | ||||||
2021-12-15 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $24.14 | -5,668 | 143,211 | -4% | -$136,826 | ||||||
2021-12-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $27.38 | -5,668 | 148,879 | -4% | -$155,190 | ||||||
| M | 2021-11-15 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $27.01 | -7,168 | 154,547 | -4% | -$193,574 | |||||
| M | 2021-11-05 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $28.06 | -16,500 | 161,715 | -9% | -$463,041 | |||||
2021-11-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $24.79 | -5,668 | 178,215 | -3% | -$140,510 | ||||||
| D | 2021-11-01 | CRNX | Fust Matthew K | Dir | S - Sale+OE | $25.50 | -8,954 | 12,536 | -42% | -$228,327 | |||||
2021-10-27 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $24.00 | -3,000 | 183,883 | -2% | -$71,991 | ||||||
2021-10-21 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $21.10 | -1,042 | 186,883 | -1% | -$21,984 | ||||||
2021-10-25 | CRNX | Perceptive Advisors LLC | 10% | P - Purchase | $19.80 | +1,200,000 | 5,163,517 | +30% | +$23,760,000 | ||||||
| D | 2021-09-08 | CRNX | Fust Matthew K | Dir | S - Sale+OE | $25.50 | -6,046 | 12,536 | -33% | -$154,173 | |||||
2021-09-07 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale | $25.00 | -30,000 | 1,165,805 | -3% | -$750,000 | ||||||
| D | 2021-07-26 | CRNX | Fust Matthew K | Dir | S - Sale+OE | $19.59 | -5,000 | 12,536 | -29% | -$97,950 | |||||
| D | 2021-07-19 | CRNX | Fust Matthew K | Dir | S - Sale+OE | $19.50 | -5,000 | 12,536 | -29% | -$97,500 | |||||
| D | 2021-07-12 | CRNX | Fust Matthew K | Dir | S - Sale+OE | $20.71 | -5,000 | 12,536 | -29% | -$103,550 | |||||
2021-04-08 | CRNX | Perceptive Advisors LLC | 10% | P - Purchase | $16.44 | +304,136 | 3,963,517 | +8% | +$4,999,996 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |